Insulin Infusion Systems: Clinical Trials

47 trials of Insulin Infusion Systems, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 8 unknown, 6 recruiting, 5 withdrawn. 22 Not applicable, 10 Phase 2, 3 Phase 3, 3 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 10, Not yet recruiting 3, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 2
Phase 210Completed 3, Recruiting 3, Withdrawn 3, Terminated 1
Phase 33Completed 2, Terminated 1
Phase 43Completed 1, Recruiting 1, Unknown 1
Phase 12Active not recruiting 1, Recruiting 1
Early Phase 11Completed 1

Follow Insulin Infusion Systems: new trials by email Literature Review of Insulin Infusion Systems trials Research Report on Insulin Infusion Systems

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Insulin Intervention After Pancreatectomy in nDM Patients
Insulin Infusion, No Insulin Infusion (Standard Monitoring Only) - Postoperative Hyperglycemia, Pancreatectomy
Not applicableNot yet recruitingDae Wook Hwang2902026-05-182026-04-21
Pilot Study of Intrapartum Insulin Pump
Insulin pump - Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2)
Not applicableNot yet recruitingMedstar Health Research Institute302026-04-012026-02-19
Physical Activity and Insulin Sensitivity Dynamics
One-legged-knee extensor exercise, Insulin infusion, Muscle Biopsy Medication: Lidocaine - Insulin Sensitivity
Not applicableRecruitingUniversity of Copenhagen82025-05-052025-12-02
Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes
insulin pump (model: AR-B200A) - Type 1 Diabetes Mellitus, Insulin Pump
Not applicableNot yet recruitingTao Yuan,MD602024-12-112024-12-19
Allo HSCT for High Risk Hemoglobinopathies
Alemtuzumab, Total Body Irradiation, Cell Infusion - Graft Failure, Sickle Cell Disease
Phase 2RecruitingMasonic Cancer Center, University of Minnesota622024-11-192026-06-04
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Rituximab, Rabbit ATG, Cyclophosphamide - Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia
Phase 2RecruitingMasonic Cancer Center, University of Minnesota602024-06-052026-06-03
Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes
Insulin pump - Type1diabetes
UnknownOregon Health and Science University802024-05-152024-04-04
T1D Closed-loop and Physical Activity
Type 1 diabetes with insulin infusion system - Diabetes type1
UnknownCentre Hospitalier Universitaire de Nice652024-05-062024-06-14
ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
Chemotherapy, Cell infusion - Hodgkin Lymphoma, Relapse
Phase 1 / Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center312024-04-252026-08-06
Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial
Hybrid Closed-loop Insulin Delivery System, Insulin pump - Diabetes Mellitus
Not applicableCompletedHuazhong University of Science and Technology542023-10-162025-05-23
mTOR as Mediator of Insulin Sensitivity Study
Exercise, Insulin infusion, Placebo - Insulin Sensitivity
Not applicableRecruitingUniversity of Copenhagen102022-02-102024-05-16
The SMART B Exercise Study :''The SMART Study''
Insulin pump - Hypoglycemia
Not applicableCompletedSteno Diabetes Center Copenhagen112021-09-142022-11-10
Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain
Insulin pump - Type 1 Diabetes
CompletedCastilla-La Mancha Health Service29772021-09-012022-02-09
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
Stepped hyperinsulinaemic-hypoglycaemic clamp study, Insulin pump, Continuous glucose monitor - Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia
Not applicableCompletedUniversity of Edinburgh242021-07-262026-01-28
Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
Single-hormone closed-loop system, Insulin pump, Continuous glucose monitoring system - Type 1 Diabetes
Not applicableCompletedInstitut de Recherches Cliniques de Montreal302020-07-102022-01-28
Faster Aspart on Insulin-pump Treated T1DM Patients
Insulin Faster Aspart, Insulin pump - Type 1 Diabetes
CompletedJesús Moreno Fernández482020-01-312021-02-01
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
12-day intervention with sensor-augmented pump therapy, 12-day intervention with single-hormone closed-loop strategy, Insulin pump - Type 1 Diabetes
Phase 2CompletedInstitut de Recherches Cliniques de Montreal362019-01-242020-06-11
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
cell infusion - Kidney Cancer
Phase 1Active not recruitingNational Heart, Lung, and Blood Institute (NHLBI)172018-07-202026-04-28
Insulin-based Strategies to Prevent Hypoglycemia During Exercise
Exercise 1, Exercise 2, Dexcom G4 Platinum - Type 1 Diabetes Mellitus
Not applicableUnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre202018-05-182018-05-22
Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels
Insulin pump, Continuous glucose monitoring system, 11-hour intervention with the single-hormone artificial pancreas - Type 1 Diabetes Mellitus
Phase 2WithdrawnInstitut de Recherches Cliniques de Montreal2018-04-012018-04-27

Showing 20 of 47. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 1 (21)  ·  Insulin Resistance (12)  ·  Hypoglycemia (7)  ·  Diabetes Mellitus (6)  ·  Motor Activity (5)  ·  Diabetes Mellitus, Type 2 (3)  ·  Pain (2)  ·  Acquired amegakaryocytic thrombocytopenia (1)  ·  Agnosia (1)  ·  Anemia, Aplastic (1)  ·  Anemia, Sickle Cell (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Pain (1)  ·  Colorectal Neoplasms (1)  ·  Diabetic Nephropathies (1)

Sponsors

Institut de Recherches Cliniques de Montreal (6)  ·  Glostrup University Hospital, Copenhagen (2)  ·  Masonic Cancer Center, University of Minnesota (2)  ·  Medtronic MiniMed, Inc. (2)  ·  Piramal Critical Care, Ltd. (2)  ·  Providence Health & Services (2)  ·  University of Copenhagen (2)  ·  Arizona State University (1)  ·  Castilla-La Mancha Health Service (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Chinese PLA General Hospital (1)  ·  Clinical Research Centre, Malaysia (1)  ·  Dae Wook Hwang (1)  ·  Huazhong University of Science and Technology (1)  ·  IKFE Institute for Clinical Research and Development (1)

Countries

United States (14)  ·  Canada (6)  ·  Denmark (5)  ·  China (2)  ·  France (2)  ·  Israel (2)  ·  South Korea (2)  ·  Spain (2)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Singapore (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Binbin Zheng, MD (1)  ·  Dae Wook Hwang (1)  ·  Dana S Hardin, MD (1)  ·  David M Thompson, MD (1)  ·  Francis J Doyle, PhD (1)  ·  Howard Zisser, MD (1)  ·  Irwani Ibrahim, MBBS (1)  ·  Isabelle Guilhem (1)  ·  Jay S. Skyler, M.D., M.A.C.P. (1)  ·  Jose Alberto Garcia Seco, RN (1)  ·  Katherine Esposito (1)

Results publications

PMID 23570538, PMID 24471561, PMID 24623024, PMID 26902791, PMID 28134564, PMID 29148821, PMID 29433562, PMID 30585770, PMID 31099946, PMID 32740723, PMID 33050728, PMID 35001477, PMID 35099281, PMID 35947087, PMID 36399114, PMID 36482870, PMID 36600427, PMID 36724311, PMID 37356876, PMID 39266213